Abstract:ObjectiveTo explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rAAV9-PDGF-B) transduction to rat cardiomyocytes in vitro.MethodsThe primary neonatal rat cardiomyocytes were isolated and cultured, and cardiomyocytes were transduced with rAAV9-PDGF-B at MOI (multiplicities of infection) = 5 × 105, and collected cardiomyocytes from different times after transduction, respectively at1, 3, 6, 14, 21, 28 days. Proteins were extracted from the cells for Western Blot analyse and observed the expression of PDGF-B, the transfection efficiency were measured by cell immunofluorescence. Alamar Blue assays were used to evaluate the safety of rAAV9-PDGF-B transduction to cardiomyocytes. And explore the cardiomyocytes which over expressed PDGF-B whether own the capacity of protecting cells against H2O2 –induced apoptosis by the test of apoptosis-related proteins and the ratio of Tunel-positive cell.ResultsCardiomyocytes were over expressed PDGF-B at the third day after transduction, and the expression of PDGF-B was increased gradually. After days 5, the expression would be stable and sustaining, such expression can last for 28 days. Cell immunofluorescence showed that approximately 78.6% cardiomyocytes overexpressed PDGF-B at days 6 after transduction. Alamar Blue assays, which evaluated the toxicity of rAAV9-PDGF-B transduction to cardiomyocytes, showed that the reduction ratios of cardiomyocytes at different times were all close to 1.0. Moreover, in Cardiomyocytes which over expressed PDGF-B, H2O2 –induced apoptosis was accompanied by the down-regulation of Bax and Tunel-positive cells, by the up-regulation of Bcl-2 and P-Akt, there was no difference between group PDGF-B+ H2O2 (P > 0.05).ConclusionsrAAV9-PDGF-B could effectively transduce cardiomyocytes cultured in vitro and persistently express PDGF-B at least 28 days. rAAV9-PDGF-B was no significant toxic effects on cardiomyocytes. Furthermore, the cardiomyocytes which over expressed PDGF-B also own the capacity of protecting cells against H2O2 –induced apoptosis, these effects might be mediated by phosphorylation of Akt signalling in cardiomyocytes.

Analysis of Differences of Expression Efficiency about Raav9 Vector with Different Promoters in Rats Myocardial Cells

Recombinant adeno-associated virus serotype 9 transfection of rat cardiac fibroblasts in vitro

Targeting transgene to the heart and liver with AAV9 by different promoters

Construction of Phospholamban Antisense RNA Recombinant Adenoassociated Virus Vector and Its Effects in Rat Cardiomyocytes

e0228 Transfection of recombinant adeno-associated virus serotype 9 to mouse heart in vivo and the effects on cardiac function

E0054 Recombinant Adeno-Associated Virus Serotype 9 Transfection of Rats H9C2 Cells in Vitro

Targeting Transgene to Heart and Liver with Aav 9 by Cmv and Cba Promoters

Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes.

Transfection of recombinant adeno-associated virus serotype 9 to mouse heart in vivo and the impact on cardiac function

Recombinant adeno-associated virus serotype 9 in a mouse model of atherosclerosis: Determination of the optimal expression time in vivo.

Feasibility and safety of adeno-associated virus serotype 9 transfection of neonatal rat cardiomyocytes

ASSA13-03-50 Transfection of Rats H9C2 Cells with Recombinant Adeno-Associated Virus Serotype 9 Mediated Anti-NF-kB Ribozyme in Vitro and Effect of Nuclear Factor-kB Activity

Recombinant adeno-associated virus serotype 9 transfection of atherosclerosis mice:determination of the optimal expression time in vivo

Comparison of the efficiency of tail vein injection and intramyocardial injection of adenovirus vector in mice

Transfection of rats H9C2 cells with recombinant adeno-associated virus Serotype 9 mediated AntiNF-κB ribozyme in vitro and effects on nuclear factor-κB activity

GW24-e0989 No Significant Difference of Adeno-Associated Virus Serotype 9 Transfection Efficiency Comparison in Different Cells

Preparation of Raav9 to Overexpress or Knockdown Genes in Mouse Hearts

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters

Enhancing transduction efficiency of adeno-associated virus 9 by cell line engineering: implication for gene therapy potency assay

ASSA13-03-40 the Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro